2017
DOI: 10.1016/j.nano.2017.05.009
|View full text |Cite
|
Sign up to set email alerts
|

Graphene nanoparticles as osteoinductive and osteoconductive platform for stem cell and bone regeneration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
51
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 51 publications
(55 citation statements)
references
References 42 publications
4
51
0
Order By: Relevance
“…Pristine graphene was modified to produce a low-oxygen functionalized form of graphene (LOG) with 6% to 10% oxygen content as reported previously. 24,37 Briefly, graphene nanoplatelets (Product # N002-PDR, 1-1.2 nm thick, ≤10 µm lateral dimensions) were commercially obtained (Angstron Materials, Dayton, OH) and subjected to an aqueous acidic environment ((conc H 2 SO 4 :conc HNO 3 : DI water, volume ratio of 6:2:3) for oxidation.…”
Section: Preparation and Characterization Of Functionalized Graphene mentioning
confidence: 99%
See 2 more Smart Citations
“…Pristine graphene was modified to produce a low-oxygen functionalized form of graphene (LOG) with 6% to 10% oxygen content as reported previously. 24,37 Briefly, graphene nanoplatelets (Product # N002-PDR, 1-1.2 nm thick, ≤10 µm lateral dimensions) were commercially obtained (Angstron Materials, Dayton, OH) and subjected to an aqueous acidic environment ((conc H 2 SO 4 :conc HNO 3 : DI water, volume ratio of 6:2:3) for oxidation.…”
Section: Preparation and Characterization Of Functionalized Graphene mentioning
confidence: 99%
“…26,27 Therefore, despite the concerns due to toxicity, graphenebased nanomaterials and scaffolds have been used successfully in animal and in vitro models of bone defects and assays. [28][29][30][31][32][33][34][35][36][37][38] Even though the results of the in vitro assays and animal models described above are encouraging and strengthen the use of graphene derivatives in biomedicine, the biocompatibility and cytotoxicity of graphene nanoparticles is altered by parameters, such as surface functionalization, shape, size, dose, cell type, and the experimental design. As a result, more research is warranted before the nanoparticles can be used effectively in a human clinical setting.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The most dominant cell types used in the included articles were mesenchymal stem cells (MSCs), including human adipose-derived stem cells (hADSCs), [17][18][19][20][21][22] Goat ADSCs, 23 human dental pulp stem cells (hDPSCs), 24 human alveolar bone marrow stem cells (hABMSCs), 25 human periodontal ligament stem cells (hPDLSCs), 26,27 and bone MSCs (BMSCs), [28][29][30][31] such as human BMSCs 19, 32-41 (hBMSCs), murine BMSCs (mBMSCs), 4, 42-49 rabbit BMSCs (rBMSCs), 50 murine MSCs cell line C3H10T1/2 51,52 and Caprine BMSCs (cMBSCs). 53 The type of the MSCs in fifteen studies 19,32,36,40,[54][55][56][57][58][59][60][61][62][63][64] was not defined.…”
Section: Cell Sourcesmentioning
confidence: 99%
“…56 Regarding the effect of GO on CS bioactivity, Xie et al 48 observed biomineralized octacalcuim phosphate (OCP), known as a beneficial agent for cell proliferation, 163 on the surface of GO-CS scaffold, significantly enhancing cell proliferation. Oyefusi et al 84 and Nair et al [23] reported that the HAP grafting onto the graphene sheets and incorporating GO nanoflakes into a Gn-HAP matrix enhanced total protein adsorption, as well as cell viability, respectively.…”
Section: Graphene and Mineralsmentioning
confidence: 99%